3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
19
Small Cell Lung Carcinoma
10
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Cholangiocarcinoma
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Oropharyngeal Neoplasms
6
Fallopian Tube Neoplasms
6
Urinary Bladder Neoplasms
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Gallbladder Neoplasms
4
Brain Neoplasms
4
Adenocarcinoma of Lung
4
Stomach Neoplasms
3
Sarcoma
3
Mouth Neoplasms
3
Mesothelioma, Malignant
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Carcinoma
3
Urethral Neoplasms
2
Triple Negative Breast Neoplasms
2
Testicular Neoplasms
2
Seminoma
2
Salivary Gland Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Peritoneal Neoplasms
2
Interventions
Vincristine
12
Temozolomide
11
Irinotecan
10
Cyclophosphamide
10
Melphalan
8
Filgrastim
8
Etoposide
7
Ifosfamide
6
Granulocyte Colony-Stimulating Factor
6
Doxorubicin
6
Vinorelbine
5
Gemcitabine
5
Busulfan
5
Thiotepa
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Dactinomycin
4
pegfilgrastim
3
liposomal doxorubicin
3
irinotecan sucrosofate
3
fludarabine
3
etoposide phosphate
3
Stem Cell Transplantation
3
Sirolimus
3
Proton Therapy
3
Cisplatin
3
Carboplatin
3
Bone Marrow Transplantation
3
thymoglobulin
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Rhabdomyosarcoma
×
Platinum
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled